Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#2285 The Role of Magnetic Resonance Imaging and Endoscopic Ultrasound Imaging in the Diagnosis and Management of Pancreatic Neuroendocrine Tumors (pNET) in Patients with Multiple Endocrine Neoplasia Type 1 (MEN1)

Introduction: Pancreatic neuroendocrine tumors (pNETs) in patients with Multiple Endocrine Neoplasia Syndrome type 1 (MEN 1) are frequently multiple and occur with an incidence that varies from 30-80% in different series. Magnetic Resonance Imaging (MRI) and techniques such as endoscopic ultrasound (EUS) are useful tools for tumor localization, size assessment and follow-up.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Tsoli M, Alexandraki K, Angelousi A, Karoumpalis I, Kolomodi D,

Keywords: pancreatic, neuroendocrine, MEN1, MRI, EUS,

#2191 Endocrine Paraneoplastic Syndromes in Patients with Neuroendocrine Neoplasms

Introduction: Endocrine paraneoplastic syndromes (ePNS) result from production of bioactive substances from tumours not related to their expected tissue of origin. Neuroendocrine neoplasms (NENs) have been associated with ectopic secretion of several hormones, but the prevalence of ePNS has only been described in a small number of studies.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Chatzellis E, Alexandraki K, Angelousi A, Tsoli M, Kaltsatou M,

Keywords: paraneoplastic syndromes, neuroendocrine neoplasms, ectopic secretion,

#2060 Peptide Receptor Radionuclide Therapy (PRRT) in 35 Patients with Metastatic Neuroendocrine Neoplasms (NENs): Overall Response and Toxicity

Introduction: Metastatic or inoperable NeuroEndocrine Neoplasms (NENs) are unresponsive to chemotherapy and targeted therapies. An emerging option is PRRT.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Liotsou T

Authors: Liotsou T, Stefanoyiannis A, Alexandraki K, Koumarianou A, Angelousi A,

Keywords: NENs, PRRT,

#1496 Sequential Everolimus and Sunitinib Treatment in Pancreatic Metastatic Well-differentiated Neuroendocrine Tumors Resistant to Prior Treatments

Introduction: Alternating treatment with sunitinib and everolimus, has been shown to be efficacious in renal cell carcinoma

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Angelousi A, Kampel K, O'Toole D, Kaltsatoy M, Boutzios G,

Keywords: everolimus, sunitinib, pancreatic NETs,